Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02705365 · ClinicalTrials.gov registry record · NA
Patient Navigation for Lung Screening at MGH Community Health Centers
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
NCT02705365: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02705365 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02705365, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
To develop and implement a patient navigator (PN) program for lung screening and smoking cessation in community health center primary care practices. This program will be evaluated in a randomized controlled trial of primary care patients who currently smoke.
Interventions
- OTHER Usual Care
- OTHER Patient Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2017-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02705365
The ClinicalTrials.gov registry entry for NCT02705365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02705365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02705365 about?
NCT02705365 is a clinical study titled "Patient Navigation for Lung Screening at MGH Community Health Centers". To develop and implement a patient navigator (PN) program for lung screening and smoking cessation in community health center primary care practices. This program will be evaluated in a randomized controlled trial of primary care patients who currently smoke.
What is the current status of trial NCT02705365?
This trial is currently completed. It is a NA study. The enrollment target is 1,200 participants. The study started on 2016-02-01. Estimated completion is 2017-02-07.
What interventions are being tested in trial NCT02705365?
The interventions under investigation include: Usual Care (OTHER), Patient Navigation (OTHER).
Who is sponsoring clinical trial NCT02705365?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.